All Article Listing | Medicap

Health News

At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.

Treating Mild High Blood Pressure Could Save Lives

Diet and exercise are key to controlling mild high blood pressure. But a new review suggests that another method of blood pressure control could also potentially save lives.

Frequent Blood Pressure Checks May Trump Doctor Test

Having high blood pressure in a test at the doctor's office may not mean you have it all the time. Monitoring blood pressure outside the doctor's office, however, may lead to more accurate results.

FDA Approves New Skin Cancer Rx

Bristol-Myers Squibb's new skin cancer drug has been approved by the US Food and Drug Administration (FDA).

Americans Cutting Back on Prepackaged Sweet Baked Goods

Prepackaged baked desserts are filling shelves but not shopping carts.

Singer Joe Cocker Dies at 70

British-born blues and rock singer Joe Cocker has died at the age of 70 after battling lung cancer.

Pure Caffeine: Not Your Regular Cup of Coffee

A federal agency is reaching out to the American public to let them know how to keep their families safe from a potentially dangerous item.

E-Readers May Impair Sleep

Love reading before bed? You may want to stick with an old-fashioned book and leave the e-reader on the charger.

Hormone Therapy Still Effective Option for Menopause

Hormones yes, hormones no — the recommendations for menopausal women have swung back and forth in the last 10 years.

Rx Combo May Trigger Serious Reactions

Some things just don't mix — and that applies to medications. One antibiotic combined with statins may be dangerous. Fortunately, other types of antibiotics may be safer when mixed with statins.

BioCryst's Rapivab Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza

BioCryst Pharmaceuticals, Inc., (Nasdaq:BCRX) a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase inhibitor for the treatment of acute uncomplicated influenza in patients 18 years and older who have been symptomatic for no more than two days.

REFINE